MedTrace Logo

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

NCT00652639 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2008-04-04

No results posted yet for this study

Summary

To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg

Conditions

  • To Determine Bioequivalence Under Fasting Conditions

Interventions

DRUG

Clonazepam

Tablets, 1 mg, single-dose

DRUG

Klonopin

tablets, 1 mg, single-dose

Sponsors & Collaborators

  • Cetero Research, San Antonio

    collaborator NETWORK

  • Par Pharmaceutical, Inc.

    lead INDUSTRY

Principal Investigators

  • Irwin Plisco · Cetero Research, San Antonio

  • Gary Shillito · Cetero Research, San Antonio

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2004-03-31
Completion
2004-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652639 on ClinicalTrials.gov